vs
德康医疗（DXCM）与美森（MATX）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是美森的1.5倍（$1.3B vs $851.9M），德康医疗净利率更高（21.2% vs 16.8%，领先4.4%），德康医疗同比增速更快（21.6% vs -4.3%），过去两年德康医疗的营收复合增速更高（12.0% vs 8.6%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
美森公司（Matson, Inc.）是美国知名航运服务企业，总部位于夏威夷州火奴鲁鲁，成立于1882年。旗下子公司美森航运主营跨太平洋海运业务，服务覆盖夏威夷、阿拉斯加、关岛、密克罗尼西亚、太平洋诸岛、中国及日本等地区。
DXCM vs MATX — 直观对比
营收规模更大
DXCM
是对方的1.5倍
$851.9M
营收增速更快
DXCM
高出25.9%
-4.3%
净利率更高
DXCM
高出4.4%
16.8%
两年增速更快
DXCM
近两年复合增速
8.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $851.9M |
| 净利润 | $267.3M | $143.1M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | 16.9% |
| 净利率 | 21.2% | 16.8% |
| 营收同比 | 21.6% | -4.3% |
| 净利润同比 | 153.6% | 11.8% |
| 每股收益（稀释后） | $0.67 | $4.47 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMMATX
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $851.9M | ||
| Q3 25 | $1.2B | $880.1M | ||
| Q2 25 | $1.2B | $830.5M | ||
| Q1 25 | $1.0B | $782.0M | ||
| Q4 24 | $1.1B | $890.3M | ||
| Q3 24 | $994.2M | $962.0M | ||
| Q2 24 | $1.0B | $847.4M |
净利润DXCMMATX
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $143.1M | ||
| Q3 25 | $283.8M | $134.7M | ||
| Q2 25 | $179.8M | $94.7M | ||
| Q1 25 | $105.4M | $72.3M | ||
| Q4 24 | $151.7M | $128.0M | ||
| Q3 24 | $134.6M | $199.1M | ||
| Q2 24 | $143.5M | $113.2M |
毛利率DXCMMATX
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMMATX
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 16.9% | ||
| Q3 25 | 20.1% | 18.3% | ||
| Q2 25 | 18.4% | 13.6% | ||
| Q1 25 | 12.9% | 10.5% | ||
| Q4 24 | 17.0% | 16.6% | ||
| Q3 24 | 15.3% | 25.2% | ||
| Q2 24 | 15.7% | 14.7% |
净利率DXCMMATX
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 16.8% | ||
| Q3 25 | 23.5% | 15.3% | ||
| Q2 25 | 15.5% | 11.4% | ||
| Q1 25 | 10.2% | 9.2% | ||
| Q4 24 | 13.6% | 14.4% | ||
| Q3 24 | 13.5% | 20.7% | ||
| Q2 24 | 14.3% | 13.4% |
每股收益（稀释后）DXCMMATX
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $4.47 | ||
| Q3 25 | $0.70 | $4.24 | ||
| Q2 25 | $0.45 | $2.92 | ||
| Q1 25 | $0.27 | $2.18 | ||
| Q4 24 | $0.37 | $3.69 | ||
| Q3 24 | $0.34 | $5.89 | ||
| Q2 24 | $0.35 | $3.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $141.9M |
| 总债务越低越好 | — | $361.2M |
| 股东权益账面价值 | $2.7B | $2.8B |
| 总资产 | $6.3B | $4.6B |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资DXCMMATX
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $141.9M | ||
| Q3 25 | $1.8B | $92.7M | ||
| Q2 25 | $1.2B | $59.1M | ||
| Q1 25 | $904.9M | $122.0M | ||
| Q4 24 | $606.1M | $266.8M | ||
| Q3 24 | $621.2M | $270.3M | ||
| Q2 24 | $939.2M | $168.2M |
总债务DXCMMATX
| Q1 26 | — | — | ||
| Q4 25 | — | $361.2M | ||
| Q3 25 | — | $370.9M | ||
| Q2 25 | — | $341.3M | ||
| Q1 25 | — | $351.1M | ||
| Q4 24 | — | $361.2M | ||
| Q3 24 | — | $370.9M | ||
| Q2 24 | — | $381.0M |
股东权益DXCMMATX
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $2.8B | ||
| Q3 25 | $2.7B | $2.7B | ||
| Q2 25 | $2.6B | $2.6B | ||
| Q1 25 | $2.3B | $2.6B | ||
| Q4 24 | $2.1B | $2.7B | ||
| Q3 24 | $2.0B | $2.6B | ||
| Q2 24 | $2.4B | $2.4B |
总资产DXCMMATX
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $4.6B | ||
| Q3 25 | $7.5B | $4.6B | ||
| Q2 25 | $7.3B | $4.5B | ||
| Q1 25 | $6.8B | $4.5B | ||
| Q4 24 | $6.5B | $4.6B | ||
| Q3 24 | $6.4B | $4.4B | ||
| Q2 24 | $6.8B | $4.3B |
负债/权益比DXCMMATX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.15× | ||
| Q2 24 | — | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $176.9M |
| 自由现金流经营现金流 - 资本支出 | — | $42.2M |
| 自由现金流率自由现金流/营收 | — | 5.0% |
| 资本支出强度资本支出/营收 | — | 15.8% |
| 现金转化率经营现金流/净利润 | — | 1.24× |
| 过去12个月自由现金流最近4个季度 | — | $153.7M |
8季度趋势，按日历期对齐
经营现金流DXCMMATX
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $176.9M | ||
| Q3 25 | $659.9M | $175.6M | ||
| Q2 25 | $303.0M | $105.6M | ||
| Q1 25 | $183.8M | $89.0M | ||
| Q4 24 | $301.4M | $174.7M | ||
| Q3 24 | $199.5M | $248.6M | ||
| Q2 24 | $279.4M | $307.9M |
自由现金流DXCMMATX
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | $42.2M | ||
| Q3 25 | $579.4M | $92.4M | ||
| Q2 25 | $208.9M | $19.3M | ||
| Q1 25 | $96.8M | $-200.0K | ||
| Q4 24 | $176.8M | $49.3M | ||
| Q3 24 | $88.3M | $189.0M | ||
| Q2 24 | $213.3M | $238.1M |
自由现金流率DXCMMATX
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | 5.0% | ||
| Q3 25 | 47.9% | 10.5% | ||
| Q2 25 | 18.1% | 2.3% | ||
| Q1 25 | 9.3% | -0.0% | ||
| Q4 24 | 15.9% | 5.5% | ||
| Q3 24 | 8.9% | 19.6% | ||
| Q2 24 | 21.2% | 28.1% |
资本支出强度DXCMMATX
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | 15.8% | ||
| Q3 25 | 6.7% | 9.5% | ||
| Q2 25 | 8.1% | 10.4% | ||
| Q1 25 | 8.4% | 11.4% | ||
| Q4 24 | 11.2% | 14.1% | ||
| Q3 24 | 11.2% | 6.2% | ||
| Q2 24 | 6.6% | 8.2% |
现金转化率DXCMMATX
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 1.24× | ||
| Q3 25 | 2.33× | 1.30× | ||
| Q2 25 | 1.69× | 1.12× | ||
| Q1 25 | 1.74× | 1.23× | ||
| Q4 24 | 1.99× | 1.36× | ||
| Q3 24 | 1.48× | 1.25× | ||
| Q2 24 | 1.95× | 2.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
MATX
| Ocean Transportation Segment | $704.2M | 83% |
| Logistics Services Segment | $147.7M | 17% |
